MORRIS PLAINS, N.J., Dec. 6, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President Finance and Chief Financial Officer, will provide a corporate overview at the Oppenheimer 22nd Annual Healthcare Conference being held December 13-14, 2011, at The Waldorf Astoria Hotel in New York City. The presentation, scheduled at 9:40 am on Wednesday, December 14, 2011, can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf.
